Asahi Life Asset Management CO. LTD. Boosts Stake in Humana Inc (HUM)

Asahi Life Asset Management CO. LTD. lifted its stake in shares of Humana Inc (NYSE:HUM) by 3.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,920 shares of the insurance provider’s stock after purchasing an additional 70 shares during the period. Asahi Life Asset Management CO. LTD.’s holdings in Humana were worth $511,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in HUM. Sumitomo Mitsui Asset Management Company LTD grew its holdings in shares of Humana by 3.2% during the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 9,831 shares of the insurance provider’s stock valued at $2,615,000 after buying an additional 307 shares in the last quarter. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Humana by 6.4% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 4,651 shares of the insurance provider’s stock valued at $1,238,000 after buying an additional 281 shares in the last quarter. Everence Capital Management Inc. grew its holdings in shares of Humana by 25.4% during the first quarter. Everence Capital Management Inc. now owns 3,198 shares of the insurance provider’s stock valued at $851,000 after buying an additional 648 shares in the last quarter. Moors & Cabot Inc. grew its holdings in shares of Humana by 77.6% during the first quarter. Moors & Cabot Inc. now owns 1,318 shares of the insurance provider’s stock valued at $350,000 after buying an additional 576 shares in the last quarter. Finally, CIBC Asset Management Inc grew its holdings in shares of Humana by 7.0% during the first quarter. CIBC Asset Management Inc now owns 16,627 shares of the insurance provider’s stock valued at $4,423,000 after buying an additional 1,085 shares in the last quarter. 94.72% of the stock is currently owned by institutional investors.

In other news, insider Roy A. Beveridge sold 8,278 shares of the company’s stock in a transaction that occurred on Tuesday, February 19th. The stock was sold at an average price of $307.16, for a total value of $2,542,670.48. Following the sale, the insider now directly owns 12,409 shares in the company, valued at approximately $3,811,548.44. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Christopher H. Hunter sold 15,586 shares of the company’s stock in a transaction that occurred on Monday, February 25th. The shares were sold at an average price of $305.24, for a total value of $4,757,470.64. Following the completion of the sale, the insider now owns 28,100 shares in the company, valued at $8,577,244. The disclosure for this sale can be found here. Corporate insiders own 0.54% of the company’s stock.

A number of research analysts have commented on the company. Credit Suisse Group lowered their target price on Humana from $390.00 to $352.00 and set an “outperform” rating on the stock in a research note on Thursday, February 7th. UBS Group started coverage on Humana in a research report on Tuesday, April 23rd. They issued a “neutral” rating and a $266.00 price target for the company. Zacks Investment Research cut Humana from a “buy” rating to a “hold” rating in a research report on Friday, February 8th. Morgan Stanley set a $331.00 price target on Humana and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Finally, Citigroup reduced their price target on Humana from $362.00 to $302.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Two analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $337.26.

Humana stock opened at $243.68 on Thursday. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $31.83 billion, a price-to-earnings ratio of 16.75, a PEG ratio of 0.97 and a beta of 0.88. Humana Inc has a 12 month low of $225.65 and a 12 month high of $355.88.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, May 1st. The insurance provider reported $4.48 EPS for the quarter, beating the consensus estimate of $4.30 by $0.18. The firm had revenue of $16.11 billion during the quarter, compared to analysts’ expectations of $15.67 billion. Humana had a return on equity of 20.77% and a net margin of 2.99%. The company’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.36 EPS. As a group, analysts expect that Humana Inc will post 17.57 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.55 dividend. The ex-dividend date is Thursday, June 27th. This represents a $2.20 annualized dividend and a yield of 0.90%. Humana’s dividend payout ratio (DPR) is 15.12%.

TRADEMARK VIOLATION WARNING: This article was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.com-unik.info/2019/05/16/asahi-life-asset-management-co-ltd-boosts-stake-in-humana-inc-hum.html.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Story: What is the Rule of 72?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit